Germany: Drug Spending Crack Down Could Mean Tougher Reference Pricing Measures
Pricing reforms in Germany could have a ripple effect elsewhere as other countries look for inspiration on how to rein in pharmaceutical spending.
You may also be interested in...
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.
Mexico aims to speed up the registration of generics and biosimilars.
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.